Genzyme may delay production plans for Myozyme
NEW YORK Genzyme said Wednesday that its plans to boost production of the drug Myozyme face possible delays, causing its shares to fall 4.3 percent despite increases in profits.
Myozyme, known generically as alglucosidase alfa, is used to treat Pompe disease, a genetic illness that impairs muscles.
Genzyme launched Myozyme in 2006, and it has since been approved in 36 countries.
Expert panel recommends lifestyle changes for pre-diabetics
NEW YORK A panel of experts from the American Association of Clinical Endocrinologists has recommended two approaches for treating patients with pre-diabetes.
In a statement released Wednesday morning, the panel recommended significant management of lifestyle to prevent the onset of diabetes. It also recommended preventing cardiovascular complications from developing.
Pre-diabetes is a condition in which patients have high levels of glucose or low tolerance to sugar, but don’t have high enough levels to be diabetic. The condition puts patients at high risk of developing Type 2 diabetes. Pre-diabetes affects 56 million Americans, according to the Centers for Disease Control and Prevention.
SF pharmacy tobacco ban up for vote
SAN FRANCISCO A San Francisco Board of Supervisors committee sent a proposed amendment to the city’s health code that would ban tobacco sales at pharmacies to the full board Thursday for a vote.
After the City Operations and Neighborhood Services Committee heard testimony from city government officials, industry representatives, anti-tobacco activists and pharmacy workers, Supervisor Carmen Chu, who chairs the committee, allowed it to go forward.
Proponents of the amendment say that pharmacies send a mixed message by selling cigarettes and medicines. Opponents call the proposed ban unfair because it exempts supermarkets and big-box stores that operate pharmacies.
The Board of Supervisors, the legislative body for the consolidated city and county of San Francisco, will vote on the amendment Tuesday.